AstraZeneca’s Brilique has been approved by NICE for use in combination with aspirin as an option to treat patients with …

GP prescriptions for Plavix saw a significant drop in England last year as doctors opted for cheaper generic forms of …
AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by the FDA. The US regulator …
Problems at a manufacturing facility in India have resulted in eight generic version of the antiplatelet agent clopidogrel being recalled …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

